Skip to content

Virtual Physical Rehabilitation for Patients Living with Long COVID

Virtual Physical Rehabilitation for Patients Living with Long COVID

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05298878
Enrollment
132
Registered
2022-03-28
Start date
2022-08-01
Completion date
2024-03-28
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Long COVID, Post COVID-19

Brief summary

The purpose of this study is to investigate whether a timely, virtual home-based physical rehabilitation program for patients living with long COVID can improve functional mobility compared to usual care.

Interventions

OTHERIntervention Group: Virtual home-based rehabilitation plus usual outpatient care

14 supervised exercise virtual sessions with Kinesiologist and 10 independent exercise sessions. Each session lasts 40 minutes. The exercises consist of aerobic training; functional lower and upper body strengthening; balance; and flexibility exercises. During the first 10 minutes of the first session of each week, there is an educational session. Week 1-2: three supervised virtual sessions Week 3-4: two supervised virtual sessions and one independent session. Week 5-8: one supervised virtual session and two independent sessions.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
RESPIPLUS
CollaboratorUNKNOWN
Santé WillKin (WillKin Health)
CollaboratorUNKNOWN
Canadian Thoracic Society
CollaboratorUNKNOWN
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(i) adult patients (18+ years old) who have had a confirmed or probable COVID-19 infection and who have self-reported persisting symptoms of either reduced mobility, muscle weakness, dyspnea, or fatigue; (ii) participants must be technologically capable of connecting (either independently or through household members) with an online videoconferencing platform through an e-mail invitation; and (iii) be able to collaborate with the research assistant to complete the virtual assessment sessions or have a family member available to help.

Exclusion criteria

(i) pre-existing or newly identified severe cognitive impairment; (ii) inability to speak or comprehend English or French; (iii) known or self-reported acute and/or uncontrolled cardiac, musculoskeletal, or neurological condition that might render rehabilitation participation unsafe.

Design outcomes

Primary

MeasureTime frameDescription
Change in the basic mobility domain of the Activity Measure for Post-Acute Care (AM-PAC)Baseline, Week 8 (up to 1 week), and at 6 months.The AM-PAC is a validated, self-reported instrument assessing activity limitations based on the International Classification of Functioning, Disability, and Health (ICF). Each item is scored from 1 (unable to perform) to 4 (none or no difficulty) with lower scores indicating lower levels of function.

Secondary

MeasureTime frameDescription
Change in functional mobilityBaseline, Week 8 (up to 1 week), and at 6 months.The fast-Timed-Up-and-Go test (TUG) assesses physical function and functional mobility. The score consists of the time taken to complete the test activity, in seconds.
Change in fatigueBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the Fatigue Visual Analog Scale.
Change in dyspneaBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the Transition Dyspnea Index.
Change in health-related quality of lifeBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the Short Form 12-item Health Survey (SF-12).
Change in lower-body strengthBaseline, Week 8 (up to 1 week), and at 6 months.The 1-minute sit-to-stand test (1-min STS) is feasible to use in hospital survivors of COVID-19. It is used to assess lower body-strength, exercise tolerance, and exertional desaturation. The score is the total number of stands within one minute.
Change in anxiety and depressionBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the Hospital Anxiety and Depression Scale.
Change in cognitive functionBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the AM-PAC Cognition Subscale.
Change in the degree of distress in response to traumaBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the Impact of Event Scale - Revised.
Self-reported health service use30 days after the 8-week period.Doctors visits, emergency department visits and hospital readmission etc.
Change in health state utilitiesBaseline, Week 8 (up to 1 week), and at 6 months.Measured by the EuroQol 5-dimension 5-level Questionnaire (EQ-5D-5L).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026